Trials / Unknown
UnknownNCT04819932
Pharmacokinetics and Safety of DWJ1451 in Healthy Adults
An Open-label, Randomized, 2x2 Crossover Study to Compare the Pharmacokinetics and Safety Following Administration of DWJ1451 and Co-administration of DWC202008 and DWC202009 in Healthy Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Amlodipine, olmesartan, total ezetimibe, rosuvastatin AUCt, Cmax
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWJ1451 | DWC202008 DWC202009 |
Timeline
- Start date
- 2021-03-13
- Primary completion
- 2021-03-13
- Completion
- 2021-04-02
- First posted
- 2021-03-29
- Last updated
- 2021-03-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04819932. Inclusion in this directory is not an endorsement.